Secarna Pharmaceuticals and Orbit Discovery Enter Collaboration to Discover and Develop Peptide-conjugated Targeted Antisense Oligonucleotide Therapeutics
Accesswire
· *Partnership expands spectrum of Secarna's capabilities for the development of targeted ASOs beyond antibodies and sugar..